Anthem Blue Cross Blue Shield of California policy

TRANS.00035 Therapeutic use of Stem Cells, Blood and Bone Marrow Products

TRANS.00035 Therapeutic use of Stem Cells, Blood and Bone Marrow Products is a public Anthem Blue Cross Blue Shield of California policy (policy TRANS.00035). It lists 27 CPT or HCPCS codes, 21 of them on the Anthem Blue Cross Blue Shield of California prior authorization list. Not a coverage decision; the payer's own document governs.

View the original policy ↗

Check eligibility for free

No account required. Sign a BAA to see plan details, coordination of benefits and more

Payer
Anthem Blue Cross Blue Shield of California
Policy number
TRANS.00035
Line of business
Commercial
Source
www.anthem.com

Codes in this policy

The CPT and HCPCS codes the policy names. A policy can name a code it excludes. Prior authorization status is from the Anthem Blue Cross Blue Shield of California prior authorization list.

CodePrior authorizationDescription on the prior authorization listOther Anthem Blue Cross Blue Shield of California policies
00011Not listedPolicies naming 00011
00035Not listedPolicies naming 00035
00110Not listedPolicies naming 00110
00132Not listedPolicies naming 00132
00155Not listedPolicies naming 00155
0232TOn the listInjection(s), platelet rich plasma, any tissue, including image guidance, harvesting and preparation when performedPolicies naming 0232T
0263TOn the listIntramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one le.g., including ultrasound guidance, if performed; complete procedure including unilateral or bilateral bone marrow harvestPolicies naming 0263T
0264TOn the listIntramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one le.g., including ultrasound guidance, if performed; complete procedure excluding unilateral or bilateral bone marrow harvestPolicies naming 0264T
0265TOn the listIntramuscular autologous bone marrow cell therapy, with preparation of harvested cells, multiple injections, one le.g., including ultrasound guidance, if performed; unilateral or bilateral bone marrow harvest only for intramuscular autologous bone marrow cell therapyPolicies naming 0265T
0481TOn the listInjection(s), autologous white blood cell concentrate (autologous protein solution), any site, including image guidance, harvesting and preparation, when performedPolicies naming 0481T
0748TOn the listInjections of stem cell product into perianal perifistular soft tissue, including fistula preparation (e.g., removal of setons, fistula curettage, closure of internal openings)Policies naming 0748T
1092TOn the listImplantation of acellular scaffold (eg, hyaluronan), knee, single implant; into chondral defect, openPolicies naming 1092T
1093TOn the listImplantation of acellular scaffold (eg, hyaluronan), knee, single implant; into a chondral or osteochondral defect, arthroscopicPolicies naming 1093T
1094TOn the listImplantation of acellular scaffold (eg, hyaluronan), knee, single implant; each additional acellular scaffold implantationPolicies naming 1094T
1095TOn the listHarvesting and processing of autologous bone marrow aspirate concentrate (BMAC), with application onto scaffold or injection into anatomical recipient site (eg, subchondral bone, joint space, chondral lesion), including imaging guidance, when performed, for therapeutic musculoskeletal treatment, excluding spinal proceduresPolicies naming 1095T
17999On the listUnlisted procedure, skin, mucous membrane and subcutaneous tissue [when specified as other abdominoplasty, excision excessive skin and subcutaneous tissue, including lipectomy, of abdomen] or [when specified as permanent hair removal by laser] or [when specified as implantation of biologic implants for soft tissue reinforcement in tissues other than breast and trunk] or [when specified as aesthetic flat chest closure or chest wall reconstruction after breast surgery] or [when specified as laser treatment of onychomycosis] or [when specified as percutaneous ultrasound ablation of subcutaneous tissue] or [when specified as application of prademagene zamikeracel (Zevaskyn) genetically engineered autologous cell therapy] or [when specified as harvesting or administration of stem cells for therapy to repair damaged cells or body tissues]Policies naming 17999
20999On the listUnlisted procedure, musculoskeletal system, general [when specified as high intensity focused ultrasound for pain palliation for bone metastases] or [No specific code for surgery using Coblation technology] or [when specified as radiofrequency or pulsed radiofrequency treatment of trigger points] or [when specified as percutaneous ultrasonic ablation of soft tissue] or [when specified as harvesting and injection of bone marrow aspirate concentrate or harvesting or administration of stem cells for therapy to repair damaged cells or body tissues]Policies naming 20999
33999On the listUnlisted procedure, cardiac surgery [when specified as percutaneous transmyocardial revascularization] or [when specified as transmyocardial transcatheter closure of ventricular septal defect, with implant, including cardiopulmonary bypass if performed] or [when specified as transcatheter replacement of tricuspid heart valve] or [when specified as autologous cell therapy for damaged myocardium, including harvesting and preparation of cells] or [when specified as use of a portable normothermic organ perfusion system for heart transplantation]Policies naming 33999
38205On the listBlood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; allogeneicPolicies naming 38205
38206On the listBlood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologousPolicies naming 38206
38230On the listBone marrow harvesting for transplantation; allogeneicPolicies naming 38230
38232On the listBone marrow harvesting for transplantation; autologousPolicies naming 38232
38999On the listUnlisted procedure, hemic or lymphatic system [when specified as use of an ex-vivo expansion of cord blood stem cell product such as omidubicel (Omisirge)] or [when specified as bone marrow cell therapy or stem cell therapy such as IM, IV or IA for peripheral vascular disease]Policies naming 38999
64999On the listUnlisted procedure, nervous system [when specified as implantation, revision, replacement, or removal of vagus nerve blocking neurostimulator electrode array or pulse generator at the esophagogastric junction] or [when specified as percutaneous neuromodulation therapy] or [when specified as introduction of Kebilidi into cranial cavity and brain] or [when specified as craniectomy or craniotomy for implantation of neurostimulator electrodes, cerebellar] or [when specified as percutaneous decompression or laser procedures of cervical or thoracic spine] or [when specified as epiduroscopy] or [when specified as pulsed radiofrequency treatment] or [when specified as cooled or pulsed RF therapy (not destruction) to genicular nerve(s)] or [when specified as cryoneurolysis] or [when specified as nanoparticle thermal ablation] or [when specified as adrenal tissue, fetal mesencephalic tissue or fetal xenograft tissue transplant to brain] or [when specified as harvesting or administration of stem cells for therapy to repair damaged cells or body tissues]Policies naming 64999
G0460On the listAutologous platelet rich plasma or other blood-derived product for non-diabetic chronic wounds/ulcers, including as applicable phlebotomy, centrifugation or mixing, and all other preparatory procedures, administration and dressings, per treatmentPolicies naming G0460
G0465On the listAutologous platelet rich plasma (PRP) or other blood-derived products for diabetic chronic wounds/ulcers, using an FDA- cleared device for this indication (includes as applicable administration, dressings, phlebotomy, centrifugation or mixing, and all other preparatory procedures, per treatment)Policies naming G0465
P9020Not listedPolicies naming P9020

All Anthem Blue Cross Blue Shield of California policies · Anthem Blue Cross Blue Shield of California prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.